P842: RAS-ERK PATHWAY GENES MUTATIONS IN THE LESIONS FROM VARIOUS TUMOR LOCI IN MULTIPLE MYELOMA

P842: RAS-ERK PATHWAY GENES MUTATIONS IN THE LESIONS FROM VARIOUS TUMOR LOCI IN MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Maiia Soloveva, Maksim Soloviev, Igor Yakutik, Bella Biderman, Elena Nikulina, Natalya Risinskaya, Tatiana Obukhova, Andrey Sudarikov, Larisa Mendeleeva
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970272.59601.28

Similar Items

Loss of Heterozygosity in the Circulating Tumor DNA and CD138+ Bone Marrow Cells in Multiple Myeloma
by: Maiia Soloveva, et al.
Published: (2023-01-01)

PB1954: COMPARING STR PROFILES OF DNA ISOLATED FROM DIVERSE TUMOR SITES IN MULTIPLE MYELOMA
by: M. Firsova, et al.
Published: (2022-06-01)

PB2145: IMPACT OF A SIZE OF BONE PLASMACYTOMA ON THE COURSE OF MULTIPLE MYELOMA
by: Elizaveta Mamaeva, et al.
Published: (2023-08-01)

Multiple myeloma with extramedullary plasmacytoma: pathogenesis and clinical case
by: M. V. Firsova, et al.
Published: (2022-11-01)

PB2344: STR-LOCI ALLELE IMBALANCE AT 9P24.1 AND PD-L1 EXPRESSION IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA.
by: Runiza Abdurashidova, et al.
Published: (2023-08-01)

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball
by: Ana Herrero, et al.
Published: (2021-09-01)

12.301 / 12.842 Past and Present Climate (12.301) / Climate Physics and Chemistry (12.842), Fall 2005
by: Wunsch, Carl, et al.
Published: (2005)

Genetic Lesions in Russian CLL Patients with the Most Common Stereotyped Antigen Receptors
by: Bella V. Biderman, et al.
Published: (2023-02-01)

16.842 Fundamentals of Systems Engineering, Fall 2009
by: de Weck, Olivier
Published: (2009)

STR loci D19S216, D20S502 and D20S842 analysis in the Serbian population using dentin DNA
by: Puzović Dragana, et al.
Published: (2011-01-01)

P842: NOVEL MULTIFUNCTIONAL TETRAVALENT CD38 NKP46 FLEX-NK ENGAGERS ACTIVELY TARGET AND KILL MULTIPLE MYELOMA CELLS
by: L. Lin, et al.
Published: (2022-06-01)

12.301 / 12.842 Climate Physics and Chemistry, Fall 2006
by: Boyle, Edward A., et al.
Published: (2006)

BRAF and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone B-cell lymphoma
by: I. A. Yakutik, et al.
Published: (2016-03-01)

Clinical features of multiple myeloma with bone plasmacytomas
by: E. A. Mamaeva, et al.
Published: (2023-03-01)

Clinical Study of the Relationship between Sjögren Syndrome and T-Cell Large Granular Lymphocytic Leukemia: Single-Center Experience
by: Vadim Gorodetskiy, et al.
Published: (2022-11-01)

The Identity of PDGFRA D842V-Mutant Gastrointestinal Stromal Tumors (GIST)
by: Alessandro Rizzo, et al.
Published: (2021-02-01)

Oncogenic mutant RAS signaling activity is rescaled by the ERK/MAPK pathway
by: Taryn E Gillies, et al.
Published: (2020-10-01)

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
by: Ufuk Degirmenci, et al.
Published: (2020-01-01)

Active Erk Regulates Microtubule Stability in H-ras-Transformed Cells
by: Rene E. Harrison, et al.
Published: (2001-01-01)

Control of Ras/Erk signalling pathway by the brahma chromatin-remodelling complex.
by: Siti Nur Ain Roesley.
Published: (2011)

Accumulation of STR-Loci Aberrations in Subclones of Jurkat Cell Line as a Model of Tumor Clonal Evolution
by: Natalya Risinskaya, et al.
Published: (2023-02-01)

The ILO and the Latin American dictatorships: an introductory approach to the study of the Case 842 against Argentina
by: Luciana Zorzoli
Published: (2017-05-01)

STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma
by: Natalya Risinskaya, et al.
Published: (2022-05-01)

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
by: Antonella Catalano, et al.
Published: (2021-04-01)

Tmsb10 triggers fetal Leydig differentiation by suppressing the RAS/ERK pathway
by: Miki Inoue, et al.
Published: (2022-09-01)

Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
by: Alessandro Papale, et al.
Published: (2016-08-01)

PB1836: LOSS OF HETEROZYGOSITY IN AML PATIENTS WITH INV(16)
by: Dmitry Bessmertniy, et al.
Published: (2023-08-01)

PB1912: BTK AND PLCG2 GENE MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH RESISTANCE TO COVALENT BTK INHIBITOR
by: Ekaterina Likold, et al.
Published: (2023-08-01)

Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
by: Cakir, M, et al.
Published: (2009)

RAS-independent ERK activation by constitutively active KSR3 in non-chordate metazoa
by: Aline Chessel, et al.
Published: (2023-07-01)

Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice
by: Ilaria Morella, et al.
Published: (2022-09-01)

PB1792: NGS VS PCR FOR THE DETECTION OF NPM1 GENE MUTATIONS IN ACUTE MYELOID LEUKEMIA.
by: N. Severina, et al.
Published: (2022-06-01)

Efficiency of pomalidomide therapy in patients with multiple myeloma refractory to lenalidomide
by: I. G. Rekhtina, et al.
Published: (2019-04-01)

Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
by: Natalya Risinskaya, et al.
Published: (2022-02-01)

MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA
by: M. V. Firsova, et al.
Published: (2018-07-01)

PB1969: FUNCTIONAL CHARACTERIZATION OF SUSCEPTIBILITY LOCI TO MULTIPLE MYELOMA
by: M. Shokouhi, et al.
Published: (2022-06-01)

ERK Dephosphorylation through MKP1 Deacetylation by SIRT1 Attenuates RAS-Driven Tumorigenesis
by: Ok-Seon Kwon, et al.
Published: (2020-04-01)

Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma
by: Marta Morante, et al.
Published: (2022-10-01)

Cefotetan-bound human RKIP involves in Ras/Raf1/MEK/ERK signaling pathway
by: Guo Chenyun, et al.
Published: (2022-12-01)

Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview
by: Eunus S. Ali, et al.
Published: (2022-08-01)